Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018078225) USE OF A SIRNA FOR TREATING CANCER
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/078225 International Application No.: PCT/FR2017/052214
Publication Date: 03.05.2018 International Filing Date: 08.08.2017
IPC:
A61K 38/18 (2006.01) ,A61K 38/189 ,A61K 38/39 (2006.01) ,A61K 31/713 (2006.01) ,A61M 5/00 (2006.01) ,A61K 9/00 (2006.01)
[IPC code unknown for A61K 38/18][IPC code unknown for A61K 38/189][IPC code unknown for A61K 38/39][IPC code unknown for A61K 31/713][IPC code unknown for A61M 5][IPC code unknown for A61K 9]
Applicants:
SELEXEL [FR/FR]; 1, Place pierre Potier 31106 Toulouse Cedex 1, FR
Inventors:
CABON, Florence; FR
BROOKS, Hilary; FR
CHUSSEAU, Maud; FR
DELMAS, Stéphanie; FR
Agent:
GROSSET-FOURNIER, Chantal; FR
BOURGOUIN, André; FR
Priority Data:
166043927.10.2016FR
Title (EN) USE OF A SIRNA FOR TREATING CANCER
(FR) UTILISATION D'UN SIRNA POUR LE TRAITEMENT DES CANCERS
Abstract:
(EN) The present invention concerns a composition comprising at least one siRNA, said siRNA hybridising with a coding or non-coding mRNA, in which it induces degradation or inhibits translation, the expression of said mRNA or of the protein for which it codes being implicated in a pathology, for the use of same in the prevention and/or the treatment of said pathology, said composition being formulated for a continuous systemic administration mode, and a device comprising such an administration mode.
(FR) La présente invention concerne une composition comprenant au moins un siRNA, ledit siRNA s'hybridant avec un ARNm, codant ou non codant, dont il induit la dégradation ou dont il inhibe la traduction, l'expression dudit ARNm ou de la protéine pour laquelle il code étant impliquée dans une pathologie, pour son utilisation dans la prévention et/ou le traitement de ladite pathologie, ladite composition étant formulée pour un mode d'administration systémique continue, ainsi qu'un dispositif comprenant un tel mode d'administration.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: French (FR)
Filing Language: French (FR)